Skip to main content
On behalf of Scientific Committee we cordially invite you to participate at the 17th International Conference on Clinical and Experimental Ophthalmology to be held during October 01-03, 2018 at Moscow, Russia. The theme of the conference is “An eye on the update of ophthalmology” which highlights the significance of vision and also explores the spectrum of latest technological developments in the field of Ophthalmology.

The 17th International Conference on Clinical & Experimental Ophthalmology which is going to be held during October 01-03, 2018 at Moscow, Russia which brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. Ophthalmology 2018 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Retina and Retinal DisordersCornea and External Eye DiseaseNeuro-OphthalmologyGlaucoma: Visual Field LossEye CancerOcular Microbiology and Immunology, Novel Approaches to Ophthalmology Therapeutics and many more.
ConferenceSeries Ltd Organizes 300+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Retinal disorders, optic atrophy, and lesions of the higher visual pathways are the main anatomical causes of visual loss in children. WHO reports that, 285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision. About 90% of the world’s visually impaired live in low-income settings 82% of people living with blindness are aged 50 and above. Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries. Many European associations are involved in Ophthalmology and many eye banks are actively promoting the donation of eyes in Europe, addressing a gap in the ophthalmic market, the global ophthalmic market was valued at $10.3 billion in 2010 and is estimated to reach $13.2 billion in 2017.
Ophthalmology is the one of the branch of medicine which deals with the science of eye and providing the insights of anatomy, physiology along with the diseases of the eye ball. An ophthalmologist is a physician who is responsible for screening of eyes, diagnosis, treatment along with the prevention of the visual system and eye.
Ophthalmology classified into various subspecialties which involve in treating the disease or part of the eye. Ophthalmology 2018 aims to brief the insights of the following through the various brain storming scientific sessions on the following:

Popular posts from this blog

NEI Statistics
(Reuters) - Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its eyedrop, Rhopressa, as a treatment for glaucoma, two months ahead of the expected date. Glaucoma affects about 2.7 million people in the United States and is the second leading cause of blindness in the world. Rhopressa helps lower the pressure due to a build up of fluid in the eye by targeting the trabecular meshwork, the main drain through which fluid flows out of the eye. For more details:  New breakthrough in ophthalmology

In Europe the growing demand for eye care services highlight shortage of ophthalmologists

The population of Europe is projected to become older in the coming decades, with an uneven growth rate expected in the various countries. The percentage of the total population age 65 years or older is predicted to increase from 17% in 2008 to 23.5% in 2030. According to the EUREYE study, 3.3% of the European population age 65 years or older has AMD . The prevalence is 40% higher in women than men and rises steeply with age. This indicates approximately 2.5 million AMD cases within the 27 EU nations. Data from the International Diabetes Federation show that there are currently 55 million adults and 112,000 children with diabetes in Europe; 10 million to 12 million more cases are expected by 2030.